<DOC>
	<DOCNO>NCT01113346</DOCNO>
	<brief_summary>This phase II double blind multicenter randomize placebo-controled clinical study aim find whether treatment Filtrum-STI ( orally administer 0,4g tablet ) safe effective child viral gastroenteritis . Filtrum-STI ( lignin hydrolytic ) drug high absorb ability , bind eliminates toxin , pathogenic microorganism virus . Filtrum-STI inoffensive mucous membrane , enhance colonic propulsion improve natural microflora . The drug toxic well combine medication</brief_summary>
	<brief_title>A Pilot Study Filtrum-STI Children With Viral Gastroenteritis</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Enteritis</mesh_term>
	<mesh_term>Adenovirus Infections , Human</mesh_term>
	<mesh_term>Enterovirus Infections</mesh_term>
	<criteria>child age 04 y.o . diagnose moderate viral gastroenteritis ; 72 h less onset gastrointestinal symptom . severe disease ; individual intolerance FiltrumSTI treatment antiviral , immunomodulatory drug study 2 week inclusion treatment pre pro antibiotic 2 week inclusion participation clinical study 1 month inclusion participation study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>enterosorbent</keyword>
	<keyword>sorbent</keyword>
	<keyword>gastrointestinal decontamination</keyword>
	<keyword>viral diarrhea</keyword>
	<keyword>rotavirus</keyword>
	<keyword>Filtrum</keyword>
	<keyword>Filtrum-STI</keyword>
	<keyword>lignin</keyword>
</DOC>